ClinicalTrials.Veeva

Menu

Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis (ACTIVMUCO)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Enrolling

Conditions

Cystic Fibrosis

Treatments

Other: Characterize the physical activity and sedentary lifestyle profile of adults with cystic fibrosis

Study type

Observational

Funder types

Other

Identifiers

NCT06507956
2024-A01077-40 (Other Identifier)
69HCL23_1132

Details and patient eligibility

About

Cystic fibrosis is a multisystem genetic disease whose severity, linked to the nature of the mutation in the gene carried, is linked to respiratory impairment, which determines the vital prognosis.

Considerable progress has been made in the management of this disease, amplified in recent years by the arrival of CFTR (cystic fibrosis transmembrane conductance regulator) modulator drugs, and in particular the triple treatment combination of elexacaftor-tezacaftor-ivacaftor (ETI). This modulator therapy improves clinical condition, particularly respiratory, and transforms quality of life and prognosis for some patients. Faced with this clinical improvement, practices and care paths are adapting. Professionals will have to cope with the emergence of new clinical conditions linked to the ageing of this at-risk population and the functional decline due to a sedentary lifestyle and age.

The working hypothesis is that a better understanding of the physical activity and sedentary lifestyle profiles of the adult population with cystic fibrosis, and in particular the characterization of the profile of inactive and high sedentary patients under ETI, will enable us to identify and target patients whose lifestyle habits reflect a greater health risk, and for whom care by rehabilitators and adapted physical activity (APA) teachers and personalized advice could be put in place.

The aim of this study is to characterize the physical activity and sedentary profile of adults with cystic fibrosis.

ACTIVMUCO is an observational, cross-sectional, single-center study. A subgroup of adults with high sedentary and inactive under ETI will be studied more specifically by actimetry (prospective follow-up) and interview.

Enrollment

270 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients (male or female) of legal age,
  • Patients with cystic fibrosis (CF) regularly followed at Hôpital Lyon Sud's cystic fibrosis center, who volunteered to take part in the study.

Exclusion criteria

  • People who, due to the presence of co-morbidities, do not have motor and cognitive skills compatible with independent walking or orthostatic physical activity.
  • People whose clinical situation contraindicates the practice of adapted physical activity
  • Pregnant women
  • People who do not have the intellectual or linguistic capacity to understand the questionnaires
  • Persons deprived of their liberty by judicial or administrative decision
  • Persons under psychiatric care
  • Persons admitted to a health or social establishment for purposes other than research
  • Adults under legal protection (guardianship, curatorship).
  • Persons not affiliated to a social security scheme or beneficiaries of a similar scheme

Trial design

270 participants in 1 patient group

Adults with cystic fibrosis followed at Hôpital Lyon Sud's cystic fibrosis center-single-arm study.
Treatment:
Other: Characterize the physical activity and sedentary lifestyle profile of adults with cystic fibrosis

Trial contacts and locations

1

Loading...

Central trial contact

Raquel Sandra REIS DE CASTRO AZEVEDO; Quitterie REYNAUD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems